Philip Bejon
Director Modernising Medical Microbiology
I was Director of the KEMRI-Wellcome Trust Research Programme up to January 2024, and was based in Kenya for 10 years. I am now based in Oxford, as Director of the Modernising Medical Microbiology Unit, where I work on antimicrobial resistance, bone infection, and pathogen genomics. I continue to work with colleagues based in Kenya on controlled human malaria infection studies, and on evaluations of malaria vaccines in the field, on validating definitions of severe malaria, studies of naturally acquired immunity to malaria, evaluations of Ebola and Yellow Fever vaccines, and on the epidemiology and immunology of COVID in Kenya.
Visit Philip's profile page for Modernising Medical Microbiology
Recent publications
-
Establishing laboratory reference ranges for adults and children in Kilifi, Kenya
Downs LO. et al, (2024)
-
The mRNA content of plasma extracellular vesicles provides a window into molecular processes in the brain during cerebral malaria
Kioko M. et al, (2024), Science Advances, 10
-
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349
-
Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast
Karisa J. et al, (2024), Wellcome Open Research, 8, 151 - 151
-
Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya
Sang S. et al, (2024)